MCVI Grand Rounds Evaluation - November 15, 2023

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence

	5	4	3	2	1
Integrate both clinical and genetic risk scoring into practice to enable earlier and tailored prevention strategies for cardiovascular disease.	Integrate both clinical and genetic risk scoring into practice to enable earlier and tailored prevention strategies for cardiovascular disease. - 5	Integrate both clinical and genetic risk scoring into practice to enable earlier and tailored prevention strategies for cardiovascular disease. - 4	Integrate both clinical and genetic risk scoring into practice to enable earlier and tailored prevention strategies for cardiovascular disease. - 3	Integrate both clinical and genetic risk scoring into practice to enable earlier and tailored prevention strategies for cardiovascular disease. - 2	Integrate both clinical and genetic risk scoring into practice to enable earlier and tailored prevention strategies for cardiovascular disease. - 1

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Recognize the contribution of genetic factors to atherosclerotic cardiovascular disease.	Recognize the contribution of genetic factors to atherosclerotic cardiovascular disease. - 5	Recognize the contribution of genetic factors to atherosclerotic cardiovascular disease. - 4	Recognize the contribution of genetic factors to atherosclerotic cardiovascular disease. - 3	Recognize the contribution of genetic factors to atherosclerotic cardiovascular disease. - 2	Recognize the contribution of genetic factors to atherosclerotic cardiovascular disease. - 1
Describe the clinical utility of genetic factors to prioritize therapeutic targets and causal biomarkers.	Describe the clinical utility of genetic factors to prioritize therapeutic targets and causal biomarkers. - 5	Describe the clinical utility of genetic factors to prioritize therapeutic targets and causal biomarkers. - 4	Describe the clinical utility of genetic factors to prioritize therapeutic targets and causal biomarkers. - 3	Describe the clinical utility of genetic factors to prioritize therapeutic targets and causal biomarkers. - 2	Describe the clinical utility of genetic factors to prioritize therapeutic targets and causal biomarkers. - 1
Outline the evidence supporting a clinical role of polygenic risk scoring in coronary artery disease prevention.	Outline the evidence supporting a clinical role of polygenic risk scoring in coronary artery disease prevention. - 5	Outline the evidence supporting a clinical role of polygenic risk scoring in coronary artery disease prevention. - 4	Outline the evidence supporting a clinical role of polygenic risk scoring in coronary artery disease prevention. - 3	Outline the evidence supporting a clinical role of polygenic risk scoring in coronary artery disease prevention. - 2	Outline the evidence supporting a clinical role of polygenic risk scoring in coronary artery disease prevention. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? *

Please provide any additional comments or suggestions.

How did you hear about this course? Other...

Name

You are here

MCVI Grand Rounds Evaluation - November 15, 2023